Created: April 26, 2021 04:02 AM
Some students in the Guilderland Central School District will be learning remotely Monday, following a cyber attack on the district.
The superintendent says the attack happened last Thursday, and they are trying to determine if any sensitive data from the district may have been affected.
The district hopes to restore internet access by Tuesday. In the meantime, students in grades 7-12 will learn remotely on Monday.
Copyright 2021 - WNYT-TV, LLC A Hubbard Broadcasting Company
Most Read Stories
3 schools on pause again just days after classes resume
Officials at Guilderland and North Colonie say COVID-19 cases caused staff shortage
FacebookTwitterEmail
Exterior of Guilderland High School on Thursday, Oct. 4, 2018, in Guilderland, N.Y. Albany County Comptroller Michael F. Conners II is upset with the school district over what he says are deceptive budget voting practices geared towards low turnout. He believes school districts should hold budget votes in conjunction with primary and general elections. (Will Waldron/Times Union)Will Waldron
Two Capital Region high schools and a middle school are shifting students to remote learning format just three days after they returned from winter break.
Created: January 07, 2021 12:05 PM
The North Colonie Central School District is moving to remote learning through Jan. 15 for grades 8-12.
The Guilderland Central School District say they will be moving to remote learning Thursday, January 7 and Friday, January 8 for grades 8-12.
Copyright 2021 - WNYT-TV, LLC A Hubbard Broadcasting Company
Related Stories
Coronavirus live updates: Advisory panel recommends FDA authorize Pfizer COVID-19 vaccine
News staff
FacebookTwitterEmail 6
1of6This illustration picture taken on November 23, 2020 shows a bottle reading Vaccine Covid-19 and a syringe next to the Pfizer and Biontech logo. (JOEL SAGET/AFP via Getty Images/TNS)Joel Saget/afp/TNSShow MoreShow Less
2of6FILE - In this March 16, 2020, file photo, a subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. According to results released on Tuesday, July 14, 2020, early-stage testing showed the first COVID-19 vaccine tested in the U.S. revved up peopleas immune systems the way scientists had hoped. The vaccine is made by the National Institutes of Health and Moderna Inc. (AP Photo/Ted S. Warren, File)Ted S. WarrenShow MoreShow Less